Scinus Group
Develops and distributes bioreactor technology for stem cell cultivation.
About
Scinus Group is a Dutch startup that develops and distributes advanced bioreactor technology for the cultivation of stem cells. Their flagship product, the Osilaris cell expansion platform, is a closed, automated, and GMP-compliant system designed to address the manufacturing challenges in cell therapies. The platform enables dynamic cell expansion, gentle processing with proprietary oxygenation and mixing, and minimizes contamination risks. Teams look it up for Biotechnology, Healthcare, Medical Devices.
Frequently asked
What does Scinus Group do?
Scinus Group is a Biotechnology company that offers Hardware. Teams look it up for Healthcare, Medical Devices, Life Sciences. It is based in Utrecht, Netherlands and was founded in 2016. Public records show $3M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Scinus Group raised?
Scinus Group has raised a total of $3M in funding. The most recent round on record is strategic investment.
Where is Scinus Group headquartered?
Scinus Group is headquartered in Utrecht, Netherlands.
When was Scinus Group founded?
Scinus Group was founded in 2016.
What industry does Scinus Group operate in?
Scinus Group operates in Biotechnology, Healthcare, Medical Devices, Life Sciences, Biotech.
What is Scinus Group's current status?
Scinus Group's current operating status is: Inactive.